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Abstract
Background: Sexually transmitted infection (STI) partner services (PS) allow provision of 
human immunodeficiency virus (HIV)/STI prevention interventions to high-risk individuals, 
including testing reminders via short message service (SMS).
Methods: In King County, Washington, PS attempt to reach all men who have sex with men 
(MSM) with early syphilis and those with gonorrhea or chlamydia as resources allow. Since 2013, 
PS offered quarterly SMS testing reminders. We evaluated correlates of reminder uptake and the 
association between reminder uptake and postinterview asymptomatic STI diagnosis using Poisson 
regression, and the association between preinterview SMS reminder use and intertest interval 
among HIV-negative MSM using median regression.
Results: During July 1, 2013 to January 17, 2018, 8236 MSM were reported with 1 or more STI 
diagnoses and 5237 received PS interviews. Of these, 4087 (78%) were offered SMS reminders; 
545 (13%) accepted, 265 (7%) were already receiving SMS, 3277 (80%) refused. Of 2602 patients 
who refused and were asked about other reminders, 37% used none, 16% received reminders from 
medical providers, 20% tested at routine physicals, and 26% used other reminders. SMS reminder 
use before and after PS interview was associated with negative HIV status, younger age, and 
diagnosis with gonorrhea or chlamydia (vs. syphilis) (P < 0.05 for all). Preinterview intertest 
interval was longer among MSM testing at physicals (9.6 months) than those using no reminder 
(5.6), SMS reminders (4.7, P < 0.05 vs. physicals), and non-SMS reminders (3.6, P < 0.001 vs. 
SMS). Reminder uptake was not associated with postinterview STI diagnosis.
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Conclusions: Offering SMS reminders through STI PS is feasible. Uptake was low, but higher 
among young MSM not on preexposure prophylaxis. The SMS reminders may increase testing 
frequency.
The US burden of bacterial sexually transmitted infections (STIs) (syphilis, chlamydia, and 
gonorrhea) and human immunodeficiency virus (HIV) is concentrated in men who have sex 
with men (MSM). Although they make up 2% of the US population, MSM experienced 
68.2% of the 30,644 cases of primary and secondary syphilis in 2017,1 and 67% of the 
40,324 new HIV diagnoses in 2016.2 Centers for Disease Control and Prevention guidelines 
recommend that MSM test at least annually for syphilis, chlamydia, gonorrhea, and HIV, to 
enable timely linkage to care and prevention of future transmission. More frequent HIV and 
STI testing, every 3 to 6 months, is recommended for MSM with a prior STI or HIV 
diagnosis, or those taking HIV preexposure prophylaxis (PrEP).3,4 Promoting regular STI 
and HIV testing of individuals at risk is a high priority for HIV/STI prevention and control 
efforts. Mathematical models suggest that increasing HIV/STI testing frequency could 
decrease the incidence of several infections.5–7
STI partner services (PS) present an opportunity to link all individuals diagnosed with STIs
—who are at elevated risk of subsequent infection—to prevention services, including regular 
testing for STIs and HIV.8 How to most effectively promote testing is unclear. One 
promising and affordable approach to increase HIV/STI testing frequency is the use of 
automated SMS reminders. The vast majority of Americans (95%) own a mobile phone and 
have access to SMS communication; access is highest among people aged 18 to 29 years 
(100%), lowest among those age 65 years and older, and varies little by race and ethnicity 
(98%, 97%, and 94% among black, Hispanic, and white, respectively).9 SMS interventions 
have been shown to improve retention in care and medication adherence in people living 
with HIV.10–12 Data on the impact of SMS reminders on HIV/STI testing are less 
conclusive.13,14 Increased HIV or STI testing rates have been reported in recipients of SMS 
reminders in observational pre-post studies,15–18 a quasi-experimental study,19 and 
randomized studies20,21; however, one pre-post study22 did not detect any impact of SMS 
reminders on testing. Additionally, prior studies have not examined client characteristics 
associated with SMS reminder uptake, leaving open the question of which client populations 
are most likely to take up and benefit from this intervention if offered in public health 
practice.
Since July 2013, PS in King County, Washington, have offered quarterly SMS reminders for 
HIV and STI testing to MSM diagnosed with early syphilis, gonorrhea, and/or chlamydia. 
This initiative was delivered as part of a broader effort to leverage STI PS for HIV 
prevention in Washington State, where greater than 70% of people living with HIV are 
MSM.23,24 In this program evaluation, we present data on uptake of SMS testing reminders 
offered through STI PS and their impact on HIV/STI testing frequency.
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MATERIALS AND METHODS
STI Case Reporting
Medical providers in Washington State are legally required to complete a case report for 
each person they diagnose with syphilis, gonorrhea, or chlamydia. Clinical laboratories are 
also required to report these infections, and public health staff follow-up on laboratory-
reported cases to ensure case reports are complete. The case report includes gender of sex 
partners and anatomical site of gonococcal and chlamydial infection, allowing health 
departments to identify MSM.
Partner Services SMS Reminder Intervention
Since 2012, PS in King County, Washington, have attempted to reach all MSM with early 
syphilis and those with gonorrhea or chlamydia as resources allow. Resource allocation was 
based on available funding, with priority given to untreated individuals and those who could 
be linked with other services offered by the public health department. In July 2013, PS 
began offering quarterly SMS testing reminders to interviewed MSM, using an external 
vendor, 2SMS25; HIV-positive MSM were offered STI testing reminders, and HIV-negative 
MSM were offered HIV/STI testing reminders. The computer-based questionnaire used for 
data collection in the PS interview displayed a standardized script to prompt the PS 
interviewer to offer SMS reminders. The content of the SMS reminders was: “It’s time for 
your follow-up testing at Harborview” (Harborview is a large county hospital with several 
outpatient clinics, including an HIV clinic and the county STD clinic). From February 2014, 
men who refused SMS were asked if they used another type of reminder.
Study Population and Data Sources
This analysis used STI surveillance and PS data, matched to the Washington State Enhanced 
HIV/acquired immune deficiency syndrome Reporting System. The analysis was restricted 
to MSM, defined as individuals identified as cis or trans male gender in their case report 
form or PS interview, and who met any of the following criteria: (1) they reported sex with 
men in the prior year during PS interviews, (2) their provider indicated male sex partners on 
the case report, or (3) they were diagnosed with rectal gonorrhea or rectal chlamydia. The 
STI diagnoses between July 1, 2013, and January 17, 2018. All activities were part of public 
health program evaluation and therefore not considered human subjects research.
Statistical Analysis
We conducted analyses to determine (1) the level and correlates of SMS reminder use at and 
before PS interviews, and (2) the effect of SMS reminder use on HIV/STI testing frequency.
We identified correlates of SMS use before PS interview and correlates of SMS acceptance 
at PS interview using Poisson regression with robust standard errors. For clients with 
multiple PS interviews at which they were offered SMS reminders, only the first response 
was included in all analyses to standardize the exposure definition in all clients to 1 offer of 
SMS reminders. Thirty-two individuals who initially refused SMS reminders subsequently 
accepted them; these are counted as refused in this analysis. Univariable and multivariable 
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analyses were conducted; all variables significantly associated with SMS use/acceptance in 
univariable analysis at a P value of 0.1 or less were included in the multivariable model.
We assessed the effect of SMS reminders on testing through two approaches: (1) association 
between SMS reminder use and testing frequency before PS interview, and (2) association 
between acceptance of SMS reminders at PS interview and subsequent testing.
We determined the association between SMS reminder use before PS interview and time 
from most recent HIV test to the current STI diagnosis using median regression. Time from 
last HIV test was used as a proxy for HIV and STI testing frequency and was determined 
based on client self-report in the PS interview.26,27 Data on past bacterial STI testing were 
not available, but last HIV test was chosen as a proxy based on the observation that HIV 
testing among MSM diagnosed with bacterial STIs is near universal in King County.28 This 
analysis was restricted to HIV-uninfected men diagnosed with an asymptomatic STI. 
Asymptomatic STIs were defined as rectal or pharyngeal chlamydia or gonorrhea, urethral 
chlamydia without symptoms, or early latent syphilis. Site of infection was based on case 
report; symptoms were based on case report and PS interview. Analysis was restricted to 
asymptomatic STIs because symptoms would be expected to influence care seeking and 
restricted to HIV-uninfected men because HIV-infected men would not be expected to test 
routinely for HIV. This analysis was additionally restricted to diagnoses after February 1, 
2014, when data on non-SMS reminder use began being collected. Unadjusted and adjusted 
analyses were conducted; all variables identified as univariable correlates of SMS reminder 
use before PS interview at a P value of 0.1 or less were included in the adjusted analysis.29
We determined the association between SMS reminder uptake at PS interview and 
subsequent diagnosis with an asymptomatic STI within 1 to 12 months after the initial STI 
diagnosis, using Poisson regression with robust standard errors. This analysis was restricted 
to asymptomatic STIs because symptoms would be expected to influence care seeking. This 
analysis was also restricted to initial diagnoses before January 17, 2017 (1 year before data 
freeze) to allow all cases equal opportunity to experience the outcome. Unadjusted and 
adjusted analyses were conducted; all variables identified as univariable correlates of SMS 
reminder uptake at PS interview at a P value of 0.1 or less were included in the adjusted 
analysis.
All analyses were conducted in Stata version 13 (College Station, TX). A P value cutoff of 
0.05 was used to determine statistical significance.
RESULTS
Participant Characteristics
Between July 1, 2013, and January 17, 2018, medical providers and laboratories reported 
cases of bacterial STI in 8236 unique MSM in King County. Of these, public health staff 
interviewed 5237 (64%) MSM for PS, and offered 4087 (78%) of them SMS reminders. 
Proportions interviewed by PS were similar across race and age groups, but varied by STI 
and HIV status: 76% of syphilis cases were interviewed compared with 36% of chlamydia 
cases, and 98% of HIV-negative compared with 51% of HIV-positive cases. Table 1 
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summarizes the demographic characteristics of MSM offered SMS reminders. Most men 
were white (62%) or Hispanic/Latinx (18%) and younger than 35 years (62%). Four hundred 
sixty (11%) cases were diagnosed with early syphilis (with or without other STIs), 2380 
(58%) with gonorrhea in the absence of early syphilis, and 1247 (31%) with chlamydia 
alone. Around a quarter of participants (24%) were known to be living with HIV, and 30% 
of HIV-uninfected men were using PrEP.
Uptake and Prior Use of SMS Reminders
Among 4087 MSM offered SMS testing reminders during PS interviews, 545 (13%) 
accepted (Fig. 1). Two hundred sixty-five men (7%) were already receiving SMS reminders 
for HIV/STI testing through enrollment outside of PS (from community organizations or 
websites), and the remaining 3277 (80%) refused. Of those who refused, 2602 were asked 
what, if any, non-SMS reminder systems they were using to prompt them to test for HIV/
STI. Approximately a quarter (679, 26%) used reminders, such as smartphone apps, 
calendar reminders, notes to self, or other un-specified methods; 531 (20%) tested as part of 
HIV well-care visits or routine physical examinations; 425 (16%) were reminded to test by 
health care providers outside of Public Health-Seattle & King County; 967 (37%) had no 
reminder in place.
Table 2 summarizes the characteristics associated with already using SMS reminders at the 
time of initial PS interview through enrollment from another source. In univariable analysis, 
already using SMS reminders was associated with younger age (9% of men ≤24 years old 
accepted SMS reminders vs. 3% of men ≥45 years old), diagnosis by an HIV/STI specialist 
provider (defined as an STI clinic, HIV/STI testing program, or medical provider 
specializing in HIV or STI care or MSM health; 9% uptake among those diagnosed by a 
specialist vs. 2% diagnosed by nonspecialist), and not having health insurance (11% uptake 
among uninsured vs. 6% among insured). Prior SMS reminder use was associated with type 
of STI diagnosis: it was highest among men diagnosed with chlamydia only (8% uptake), 
followed by those diagnosed with gonorrhea (7%), and significantly lower among men 
diagnosed with syphilis (1%). Reminder use was also associated with HIV status: it was 
significantly higher among HIV-negative men not using PrEP (8%) than HIV-positive men 
(1%). There was also a secular decline in SMS reminder use over calendar time (relative risk 
(RR), 0.81 [0.73–0.89] per calendar year increase). In multivariable regression, use of SMS 
reminders before PS interview was associated with younger age, nonsyphilis STI diagnosis, 
negative HIV status, diagnosis by an HIV/STI specialist, and earlier calendar year of 
diagnosis.
Table 3 summarizes sociodemographic, behavioral, and clinical characteristics associated 
with uptake of SMS testing reminders offered at PS interview among men who were not 
already receiving SMS before PS interview. Characteristics associated with SMS reminder 
uptake at PS interview were similar to those associated with use before PS interview. In 
univariable analyses, uptake of SMS reminders was associated with younger age (23% of 
men ≤24 years old accepted SMS reminders vs. 9% of men ≥45 years old) and nonwhite 
race/ethnicity (12% uptake by white men vs. 18% uptake by men of color). Reminder uptake 
was highest among men diagnosed with chlamydia only (19% uptake) than those with 
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gonorrhea (14%) or syphilis (2%). It was also associated with diagnosis by an STI specialist 
provider (15% uptake among those diagnosed by a specialist vs. 13%), with not having 
health insurance (23% uptake among uninsured vs. 12%), and with HIV status and PrEP 
usage (13% uptake among HIV-negative men not using PrEP, 3% among HIV-negative men 
using PrEP, and 7% among HIV-positive men). There was also a secular decline in SMS 
uptake over calendar time (RR, 0.56 [0.52–0.60] per calendar year increase). In 
multivariable regression, SMS reminder uptake remained associated with younger age, STI 
diagnosis, HIV-negative status not using PrEP, and earlier calendar year of diagnosis (P < 
0.05 for all).
Association Between SMS Reminder Use and HIV/STI Testing Before PS Interview
We evaluated the association between SMS use before PS interview and time from last 
negative HIV test to the current STI diagnosis, among HIV-uninfected men diagnosed with 
an asymptomatic STI. Among 1457 men included in this analysis, 167 (12%) were using 
SMS reminders, 52 (4%) were tested as part of routine physicals, 724 (50%) used other non-
SMS reminder systems, and 514 (35%) had no reminder system in place. Table 4 
summarizes the median time since last HIV test by testing reminder. Overall, the median 
time since last HIV test was 4.1 months (IQR 2.9–7.7). Median time since last HIV test was 
shortest in men using non-SMS reminders, such as apps, calendar reminders, or reminders 
from providers outside Public Health-Seattle and King County (3.6 months [2.6–5.7]), 
followed by those using SMS reminders (4.7 months [3.1–7.7]), no reminder (5.6 months 
[3.3–10.7]), and physicals (9.6 months [4.0–17.5]). In multivariable analysis adjusted for 
client characteristics associated with SMS uptake before PS (age, PrEP use, STI, health 
insurance status, diagnosing provider and calendar year) men using physicals as their 
reminder had a significantly longer time since last HIV test, compared with men using SMS 
reminders (β, 4.33 [2.86 to 5.81]). There was a nonsignificant trend for longer time since last 
test in men using no reminder compared with those using SMS reminders (β = 0.80 [−0.08 
to 1.68]).
Association Between SMS Reminder Uptake and Asymptomatic STI Diagnosis After PS 
Interview
The second measure of association between SMS reminder uptake and testing frequency was 
repeat diagnosis with an asymptomatic STI 1 to 12 months after initial STI diagnosis. Of 
3376 men who were offered SMS reminders and included in this analysis, 759 (23%) had a 
subsequent asymptomatic STI diagnosis within 1 to 12 months (Table 5). The frequency of 
subsequent diagnosis with an asymptomatic STI was not significantly associated with SMS 
reminder uptake at PS interview (19% subsequently diagnosed) or having been enrolled in 
SMS reminders before PS (25% subsequently diagnosed, P > 0.05 for both). Multivariable 
regression adjusted for variables associated with uptake of SMS reminders (age, race, HIV/
PrEP status, STI, health insurance status, diagnosing provider, and calendar year) did not 
alter the effect estimates.
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DISCUSSION
In this analysis of public health programmatic data, we found that offering SMS testing 
reminders to MSM diagnosed with STIs through PS interviews was feasible, with 80% of 
clients interviewed between 2013 and 2018 being offered the service. However, SMS 
reminder uptake was low (13%) and declined over the period of analysis. Most MSM who 
refused SMS reminders cited having other reminder systems in place. SMS reminder uptake 
at PS interview was highest in younger MSM, those diagnosed with chlamydia only, and 
HIV-negative MSM who were not using PrEP. We found that HIV-negative MSM who used 
SMS reminders before PS interview had a shorter time since last HIV test (used as a proxy 
for STI testing frequency) compared with those using annual physical examinations as a 
reminder, and a trend for shorter time compared with those using no reminders. However, 
postinterview diagnosis with an asymptomatic STI was not associated with SMS reminder 
use either before or as a result of PS interview.
SMS messaging has been identified as a promising intervention to promote regular HIV/STI 
testing based on 3 main premises. First, SMS messaging is considered a relatively feasible, 
affordable intervention that places lower burden on the health system than in-person testing 
promotion or phone calls. Second, use of mobile technology, which now has almost 
universal penetration in the US,9 has been proposed to be effective at reaching communities 
underserved by clinic-based contact with the health system.30 This approach may therefore 
enable greater promotion of HIV/STI testing among hard-to-reach populations, who may 
also be the populations at highest risk of HIV/STI acquisition. Finally, several studies have 
found that SMS messaging improves medication adherence among patients diagnosed with 
HIV and other chronic diseases.10–12 Fewer data exist on the impact of SMS messaging on 
HIV/STI testing,13,14 but small studies have suggested some benefit.15–21
Our findings speak to each of these premises. Consistent with prior studies,15–18,22 we found 
that offering SMS testing reminders in the context of routine service delivery was feasible. 
We also found that young age and being HIV-negative and not on PrEP were both 
independent predictors of SMS reminder up take. The latter is likely explained by 
individuals who are receiving HIV care or PrEP already receiving regular HIV/STI testing 
through their ongoing care. Nonwhite race was also associated with uptake in unadjusted 
analysis. Importantly, young MSM, particularly young MSM of color, and MSM not on 
PrEP are groups at elevated risk of HIV and STI acquisition and therefore a high priority for 
promotion of HIV/STI testing.1 These findings suggest that SMS reminders may 
preferentially be taken up by populations prioritized in testing promotion, and may therefore 
be a useful tool in addressing disparities in health system engagement. In addition, uptake at 
PS interview and use before interview were both found to differ by STI diagnosis, which 
may indicate distinct behavioral or network correlates and suggest that different approaches 
may be needed for MSM with syphilis. Although analysis of correlates of use before PS 
interview examined factors measured after the decision to use SMS reminders, current STI 
diagnosis is known to be associated with prior diagnosis and risk behavior.31 The similarity 
in correlates of SMS reminder uptake at and before PS interview suggests that offering 
reminders at PS interviews did not target a distinct population from that reached by other 
SMS reminder initiatives. Notably, although the SMS reminder intervention was feasible and 
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had higher uptake in priority groups, absolute uptake was relatively low: 13% of all 
interviewed MSM accepted reminders (23% of MSM ≤24 years), and acceptance declined 
over the data collection period. Roughly two thirds of those who refused stated that they had 
other systems in place to prompt them to test, suggesting that SMS reminders may not have 
been perceived by most MSM as offering a benefit beyond approaches that they already 
used.
Our analyses of the impact of SMS reminder use on testing frequency yielded two differing 
results. Analysis of SMS reminder use and HIV testing before PS interview indicated that 
SMS reminders were associated with more frequent testing than only testing concurrent with 
physical examinations. There was also a trend for more frequent testing in SMS users than 
those with no reminders, but no difference with users of other non-SMS reminders. This 
suggests that MSM who state they are using annual physical examinations as their reminder 
or have no testing reminder in place may benefit from targeted promotion of SMS 
reminders, and messaging that annual physicals do not constitute an adequate reminder 
system for at-risk MSM. The observational design of this study limited our ability to infer 
causality; however, our observation of shorter intertest interval when adjusting for client 
characteristics associated with SMS reminder uptake supports prior studies, suggesting that 
SMS reminders lead to more frequent testing.15,17–21 In contrast, we found no association 
between SMS reminder uptake at PS interview and STI diagnosis after it. This analysis was 
limited by our inability to ascertain testing directly using available data sources; instead, we 
relied on STI diagnosis data. It is therefore possible that testing frequency was higher among 
MSM who accepted SMS reminders, but that the underlying STI acquisition risk was lower 
in this group, impairing our ability to detect the association when evaluating STI diagnoses. 
Similarly, although a multivariable analysis was conducted adjusting for factors associated 
with SMS reminder uptake, it is possible that our estimate was residually confounded by 
other participant characteristics. Additionally, it is important to note that overall testing 
frequency in this population was high: median time since last HIV test was 4.1 months. This 
may have limited our statistical power to detect a difference in testing frequency between 
groups. Evaluation of this approach in contexts with lower baseline testing rates, with 
prospective ascertainment of testing events, and in a randomized design would be valuable.
The mechanism by which SMS messaging modifies human behavior is unclear. In the 
context of medication adherence, increasing access to information and building trust and 
two-way communication between patients and providers are thought to be important.10 The 
intervention evaluated in this study was designed as a simple reminder rather than a channel 
for education or communication with the clinic. Published SMS interventions to promote 
testing have varied in content, including reminders15–17,20 or more complex educational 
content.19,21 One study reported that personalized messages were more efficacious than 
generic reminders.17 Studies suggest that barriers to frequent HIV/STI testing include 
factors beyond forgetfulness, such as low-risk perception, anticipated stigma, and mis-trust 
of the medical system.32 It is encouraging that the simple reminders evaluated in this study 
had some association with intertest interval. Future research evaluating message content that 
addresses additional barriers to testing may yield more pronounced effects.33
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In conclusion, this work adds to the literature supporting the use of SMS messaging to 
promote HIV/STI testing. The intervention was feasibly delivered as part of an expanded PS 
program,8 reached priority groups, and was associated with some evidence of increased 
HIV/STI testing frequency. However, the magnitude of the intervention’s effect was modest: 
SMS reminder uptake was low, in part due to use of other reminder systems, and testing 
frequency in this population in the absence of SMS reminders was relatively high. The 
intervention’s cost was low: SMS messaging fees were 7.5 cents per SMS, and costing 
analysis of the expanded PS program as a whole (including SMS reminders) indicated 
marginal cost increase over standard PS.34 Given the intervention’s low cost, it may be cost-
effective even with a modest effect. Formal cost-effectiveness analysis is warranted. Use of 
this feasible, affordable intervention may reduce testing disparities and benefit individuals 
who do not have other testing reminders in place, especially if they use annual physicals as 
their testing prompt.
Acknowledgments:
The authors thank the Public Health-Seattle and King County (PHSKC) disease intervention specialists for their 
work conducting partner services as well as PHSKC epidemiology and data management staff for their work on the 
supplemental database. This program and its evaluation were supported by the Centers for Disease Control and 
Prevention [H25 PS004364]; the Washington State Department of Health; and PHSKC. The evaluation was also 
supported by the NIH [P30 AI027757].
Source of Funding: This program and its evaluation were supported by the Centers for Disease Control and 
Prevention [H25 PS004364]; the Washington State Department of Health; and Public Health-Seattle and King 
County. The evaluation was also supported by the NIH [P30 AI027757]. M.R.G. has received research support from 
GlaxoSmithKline and Hologic. J.C.D. has received research support from Hologic.
REFERENCES
1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance. 2017; 
2017:1–164.
2. Centers for Disease Control and Prevention. HIV Surveillance Report, 2016 [Internet]. Vol. 28. 2016 
[cited 2018 Sep 27]. p. 5–6; 96–97. Available from: http://www.cdc.gov/hiv/library/reports/hiv-
surveillance.html.%0Ahttp://www.cdc.gov/hiv/library/reports/hiv-surveillance.html%0Ahttp://
wwwn.cdc.gov/dcs/ContactUs/Form%0Ahttp://www.cdc.gov/hiv/library/reports/hiv-
surveillance.html.%0Ahttp://www.cdc.gov/hiv/.
3. Centers for Disease Control and Prevention. 2015 STD Treatment Guidelines [Internet]. 2015 [cited 
2018 Sep 26]. Available from: https://www.cdc.gov/std/tg2015/.
4. Public Health Seattle King County. HIV and STI Screening Recommendations [Internet]. [cited 
2018 Nov 20]. Available from: https://www.kingcounty.gov/depts/health/communicable-diseases/
hiv-std/providers/testing-msm-trans.aspx.
5. Jenness SM, Weiss KM, Goodreau SM, et al. Incidence of gonorrhea and chlamydia following 
human immunodeficiency virus preexposure prophylaxis among men who have sex with men: A 
modeling study. Clin Infect Dis 2017; 65:712–718. [PubMed: 28505240] 
6. Gray RT, Hoare A, Prestage GP, et al. Frequent testing of highly sexually active gay men is required 
to control syphilis. Sex Transm Dis 2010; 37:298–305. [PubMed: 20393383] 
7. Cassels S, Menza TW, Goodreau SM, et al. HIV serosorting as a harm reduction strategy: Evidence 
from Seattle, Washington. AIDS 2009; 23:2497–2506. [PubMed: 19834319] 
8. Golden MR, Katz DA, Dombrowski JC. Modernizing field services for human immunodeficiency 
virus and sexually transmitted infections in the United States. Sex Transm Dis 2017; 44:599–607. 
[PubMed: 28876325] 
9. Pew Research Center. Core Trends Survey. 2018.
Ronen et al. Page 9
Sex Transm Dis. Author manuscript; available in PMC 2019 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
10. Henny KD, Wilkes AL, McDonald CM, et al. A rapid review of eHealth interventions addressing 
the continuum of HIV care (2007–2017). AIDS Behav 2018; 22:43–63. [PubMed: 28983684] 
11. Cooper V, Clatworthy J, Whetham J, et al. mHealth interventions to support self-management in 
HIV: A systematic review. Open AIDS J 2017; 11:119–132. [PubMed: 29290888] 
12. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in 
chronic disease: A meta-analysis. JAMA Intern Med 2016; 176:340–349. [PubMed: 26831740] 
13. Conserve DF, Jennings L, Aguiar C, et al. Systematic review of mobile health behavioural 
interventions to improve uptake of HIV testing for vulnerable and key populations. J Telemed 
Telecare 2017; 23: 347–359. [PubMed: 27056905] 
14. Desai M, Woodhall SC, Nardone A, et al. Active recall to increase HIV and STI testing: A 
systematic review. Sex Transm Infect 2015; 91: 314–323. [PubMed: 25759476] 
15. Bourne C, Knight V, Guy R, et al. Short message service reminder intervention doubles sexually 
transmitted infection/HIV re-testing rates among men who have sex with men. Sex Transm Infect 
2011; 87: 229–231. [PubMed: 21296796] 
16. Guy R, Wand H, Knight V, et al. SMS reminders improve re-screening in women and heterosexual 
men with chlamydia infection at sydney sexual health centre: A before-and-after study. Sex 
Transm Infect 2013; 89:11–15. [PubMed: 22517890] 
17. Nyatsanza F, McSorley J, Murphy S, et al. “It’s all in the message”: The utility of personalised 
short message service (SMS) texts to remind patients at higher risk of STIs and HIV to reattend for 
testing-a repeat before and after study. Sex Transm Infect 2016; 92:393–395. [PubMed: 26670912] 
18. Zou H, Fairley CK, Guy R, et al. Automated, computer generated reminders and increased 
detection of gonorrhoea, chlamydia and syphilis in men who have sex with men. PLoS One 2013; 
8:e61972.
19. Njuguna N, Ngure K, Mugo N, et al. The effect of human immunodeficiency virus prevention and 
reproductive health text messages on human immunodeficiency virus testing among young women 
in rural Kenya. Sex Transm Dis 2016; 43:353–359. [PubMed: 27200519] 
20. Downing SG, Cashman C, Mcnamee H, et al. Increasing chlamydia test of re-infection rates using 
SMS reminders and incentives. Sex Transm Infect 2013; 89:16–19. [PubMed: 22728911] 
21. Ybarra ML, Prescott TL, Phillips GL, et al. Pilot RCT results of an mHealth HIV prevention 
program for sexual minority male adolescents. Pediatrics 2017; 140.
22. Burton J, Brook G, McSorley J, et al. The utility of short message service (SMS) texts to remind 
patients at higher risk of STIs and HIV to reattend for testing: A controlled before and after study. 
Sex Transm Infect 2014; 90:11–13. [PubMed: 24064987] 
23. Katz DA, Dombrowski JC, Barry M, et al. STD partner services to monitor and promote HIV pre-
exposure prophylaxis use among men who have sex with men. JAIDS J Acquir Immune Defic 
Syndr 2019; 80:533–541. [PubMed: 30649032] 
24. Katz DA, Dombrowski JC, Kerani RP, et al. Integrating HIV testing as an outcome of STD partner 
services for men who have sex with men. AIDS Patient Care STDS 2016; 30:208–214. [PubMed: 
27158848] 
25. 2SMS website [Internet]. Available from: www.2sms.com.
26. Katz DA, Dombrowski JC, Swanson F, et al. HIV intertest interval among MSM in King County, 
Washington. Sex Transm Infect 2013; 89:32–37. [PubMed: 22563016] 
27. Helms DJ, Weinstock HS, Mahle KC, et al. HIV testing frequency among men who have sex with 
men attending sexually transmitted disease clinics: Implications for HIV prevention and 
surveillance. JAIDS J Acquir Immune Defic Syndr 2009; 50:320–326. [PubMed: 19194309] 
28. Public Health Seattle King County. Seattle and King County Quarterly STD Report: 1st Quarter 
2018. 2018.
29. Bursac Z, Gauss CH, Williams DK, et al. Purposeful selection of variables in logistic regression. 
Source Code Biol Med 2008; 3:17. [PubMed: 19087314] 
30. Arya M, Kumar D, Patel S, et al. Mitigating HIV health disparities: The promise of mobile health 
for a patient-initiated solution. Am J Public Health 2014; 104:2251–2255. [PubMed: 25322292] 
31. Katz DA, Dombrowski JC, Bell TR, et al. HIV incidence among men who have sex with men after 
diagnosis with sexually transmitted infections. Sex Transm Dis 2016; 43:249–254. [PubMed: 
26967302] 
Ronen et al. Page 10
Sex Transm Dis. Author manuscript; available in PMC 2019 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
32. Campbell CK, Lippman SA, Moss N, et al. Strategies to increase HIV testing among MSM: A 
synthesis of the literature. AIDS Behav 2018; 22:2387–2412. [PubMed: 29550941] 
33. Kumar D, Arya M. mHealth is an innovative approach to address health literacy and improve 
patient-physician communication—An HIV testing exemplar. J Mob Technol Med 2015; 4:25–30. 
[PubMed: 25729441] 
34. Silverman RA, Katz DA, Levin C, et al. Sexually transmitted disease partner services costs, other 
resources, and strategies across jurisdictions to address unique epidemic characteristics and 
increased incidence. Sex Transm Dis 2019; 46:493–501. [PubMed: 31295215] 
Ronen et al. Page 11
Sex Transm Dis. Author manuscript; available in PMC 2019 December 18.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Uptake of SMS reminders and other reminder use among MSM interviewed by partner 
services in King County, WA, 2013 to 2017.
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TABLE 1.
Sociodemographic, Clinical, and Behavioral Characteristics of MSM Offered SMS Testing Reminders 
Through STI Partner Services in King County, WA, 2013–2017
N
n (%) or
median (IQR)
Overall 4087
Age 4086
 ≤24   808 (19.8)
 25–34 1692 (41.4)
 35–44   800 (19.6)
 ≥45   786 (19.2)
Race/ethnicity* 4061
 Asian   289 (7.1)
 Black   279 (6.9)
 Hispanic/Latinx    728 (17.9)
 White  2531 (62.3)
 Other  234 (5.8)
STI 4087
 Chlamydia only 1247 (30.5)
 Early syphilis (includes co-infections)   460 (11.3)
 Gonorrhea (no syphilis) 2380 (58.2)
HIV status 4087
 Negative 3114 (76.2)
 Previous positive   942 (23.1)
 Newly diagnosed positive    31 (0.8)
Used PrEP† 2538    762 (30.0)
Diagnosed by HIV/STI specialist‡ 4087  2740 (67.0)
Has health insurance 3855  3245 (84.2)
Used methamphetamine 3816  307 (8.1)
Used inhaled nitrates 3823   995 (26.0)
Injected drugs 3803  142 (3.7)
No. sex partners in last year 3569     6 (3–12)
*
Individuals of any race who identify as Latinx are classified as Latinx.
All other groups are non-Latinx.
†Among 3114 HIV-negative.
‡
Defined as an STI clinic, HIV/STI testing program, or medical provider specializing in HIV or STI care or MSM health.
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